AzTrials
AzTrials

Deferred Umbilical Cord ClampingDoppCordNCT01864421

Physiological Effects of Deferred Cord Clamping

An observational study of Deferred Umbilical Cord Clamping, run by University of Nottingham at 1 site in United Kingdom.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

This is an observational study to see if at birth, flow of blood from a placenta to the baby can be estimated non-invasively using Doppler ultrasound and/or cutaneous perfusion measured using a novel PPG sensor. Read more about this study

Who is it for?
Ages Up to 24 hours
Conditions the study is for
Deferred Umbilical Cord Clamping
How many people
15 participants
Where
1 siteUnited Kingdom
Study dates
May 2013to May 2018
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Up to 24 hours
  • All sexes
  • No healthy volunteers
  • Child

Study population: The study will recruit babies born at or after 32 weeks with no antenatal or perinatal risk factors that may necessitate the need for resuscitation beyond normal thermal management in the delivery room.

Who may be able to join

  • Greater than ≥ 32 weeks gestation
  • With written informed parental consent

Who cannot join

  • Antenatally diagnosed problems requiring immediate intervention or problems at delivery are anticipated.
  • No realistic prospect of survival
  • No parental consent
  • Maternal death
  • Non-singleton pregnancies

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site
  • University Hospitals Nottingham NHS Trust

    Nottingham, Nottinghamshire, NG7 2UH

Other trials in United Kingdom

About this study

Official title: Delivery Room and Postnatal Assessment of the Physiological Effects of Deferred Cord Clamping on the Newborn: A Feasibility Study

This is an observational study to see if at birth, flow of blood from a placenta to the baby can be estimated non-invasively using Doppler ultrasound and/or cutaneous perfusion measured using a novel PPG sensor.

Read the detailed description

Deferred cord clamping appears to confer short term benefits for both term and preterm newborn babies. However, the optimal timing of cord clamping remains unclear, it is increasingly being hypothesised that immediate cord clamping may be disrupting a physiological process. Indeed, differences in the anatomy and physiology of the baby and placenta may lead to functional differences potentially altering the blood flow to the newborn. This may have implications for the baby if the cord is clamped too early or too late. A method of estimating the best time to clamp the cord could offer both short and long-term benefits especially in the preterm population.

Many studies have started measuring the short-term benefits of deferred cord clamping such as reduced requirements for ventilation , red cell transfusions, improved perfusion and reduced incidence of intraventricular haemorrhage. Studies are currently underway examining the long-term benefits of deferred cord clamping. However, very little is known on the background physiology of placental transfusion. Studies often use arbitrary times for clamping the cord with little reference to a scientific basis. Many of the studies included in both Cochrane reviews and meta-analysis use a variable definition of deferred cord clamping varying from 30 seconds to 5 minutes or when the cord had stopped pulsating.

There appears to be very few risks associated with deferred cord clamping. There are some reports of an increased need for phototherapy to treat jaundice but this is not consistent. Polycythaemia is also reported, however, this is known to be present in a proportion of term deliveries regardless of the time of clamping and deferred cord clamping appears to confer no greater clinical risk with no change in the incidence of hypoglycaemia or increased need for exchange transfusion. In the preterm population once the baby has delivered there are issues relating to resuscitation that also need to be addressed. For example, a baby born at 25 weeks gestation may benefit from deferred cord clamping but this will alter the timing and approach of resuscitation. A better understanding of the physiology in these instances, coupled with a reliable measure of when the majority of the placental transfusion has occurred, may guide the optimal timing of cord clamping and the initiation of resuscitation.

Other methods of assessing placental transfusion have been tried and studies are currently ongoing including weighing infants during transfusion to measure the volume and speed of blood transfusion. However, it is difficult to transfer this method to the preterm population due to concerns regarding thermoregulation and need for resuscitation.

Although a number of studies investigating the effects of deferred umbilical cord clamping have been performed there is little research on the physiology behind placental transfusion. One study has previously used Doppler to assess blood velocity in the umbilical arteries although the methodology of this study is now outdated. This study was performed using sound Doppler recordings, which were then played via tape into a continuous spectrograph analyser. With the advancement of technology and the use of colour Doppler ultrasound it is possible to more reliably and quickly quantify umbilical cord blood flow therefore eliminating the methodological flaws of the above study. A few studies have examined the rate of placental transfusion although there has been disagreement as to whether the transfusion is a steady state or a rapid decrease over the first minutes after delivery. There is also little discussion as to whether timings are individual for each foetal-placental unit.

As discussed, there seems to be a decreased requirement for red cell transfusion after deferred cord clamping which confers that infants have a higher haemoglobin concentration. Photoplethysmographic Sensors (PPG) can be used to monitor the haemodynamic status of a patient including heart rate, oxygen saturations and perfusion. PPG works by emitting a light source into tissue which is then reflected and measured, this fluctuates according to blood flow. The amount of light reflected will therefore vary according to the blood volume and hence give an assessment of haemodynamic status.

Assessing whether either Doppler or PPG provide a feasible method of measuring umbilical blood flow and its cessation will help guide us in clinical practice. Both methods involve equipment available for use in the delivery suite, they involve minimal handling of the infant which is important especially in the context of preterm deliveries and they enable the neonatal team to continue assessment and early management. The added advantage of PPG is that it can also be used to monitor the heart rate of the baby during the first minutes of life. This will provide valuable information relating to the stability of the baby during the placental transfusion.

It has been shown that neonates who undergo deferred cord clamping have an increased haemoglobin level and a lower requirement for inotropic support of their blood pressure. This improved haemodynamic status may be sustained for a period of time. Important markers of haemodynamic status include heart rate, blood pressure and capillary refill. Assessment of these markers needs to be carried out in the first few days of life and correlated with skin perfusion.

STUDY OBJECTIVES

Primary Objective:

To use Doppler ultrasound and/or PPG to improve knowledge on the physiology of deferred cord clamping and assess their use in measuring when the majority of placental transfusion has occurred. This may provide a quantitative method of guiding the optimal timing of cord clamping and the initiation of resuscitation enabling it to extend studies to preterm infants in whom this may be of greater benefit.

Secondary Objective:

To compare cardiovascular status of infants undergoing cord clamping at different ages after birth. Measure central and peripheral capillary refill time using a PPG sensor and by the investigators observation, measure non-invasive blood pressure, record heart rate by auscultation, measure haemoglobin and haematocrit.

STUDY DESIGN This is an observational study that will provide feasibility data for a larger trial with a preterm cohort.

The study will recruit babies born at or after 32 weeks with no antenatal or perinatal risk factors that may necessitate the need for resuscitation beyond normal thermal management in the delivery room.

The study has 2 elements:

Part I. Either, a Doppler probe will be applied to the umbilical cord to measure umbilical blood flow or a PPG sensor placed on the baby to monitor cutaneous perfusion. In the case of Doppler assessment the probe will be applied in a manner that does not affect blood flow.

Part II. To determine whether deferred cord clamping has an effect on cardiovascular status after delivery we will compare the cohort with deferred cord clamping to an observational control cohort and measuring indicators of cardiovascular status (blood pressure, capillary refill time, haemoglobin count). We will be assessing the capillary refill time using standardised pressure application with a PPG sensor placed centrally and peripherally on the baby. Both pressures and lengths of blanching will be variable.

Keywords
Infant, Newborn, Delivery, Obstetric, Umbilical Cord

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT01864421
Study groupRoleWhat they receive
Deferred ClampingInfants undergoing a deferring of umbilical cord clamping for 30 seconds or more
Immeadiate Cord ClampingInfants undergoing immediate umbilical cord clamping in the first 20 seconds of life.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Quantification of blood flow in the umbilical cord or skin

    The use of either Doppler ultrasound or a photoplethysmographic (PPG) sensor at delivery to measure either blood flow in the umbilical cord or the skin.

    Measured: For Doppler the umbilical cord will be scanned until it is clamped (up to 3 minutes). Blood flow to the skin will be measured for up to 20 minutes as long as this is not interfering with normal clinical care.

Secondary outcomes (1)
  1. To assess the cardiovascular status of infants undergoing deferred cord clamping in comparison to immediate clamping.

    A number of markers of cardiovascular status will be measured including central and peripheral capillary refill time using a PPG sensor and by the investigators observation, non-invasive blood pressure, heart rate, haemoglobin and haematocrit.

    Measured: In the first 3 days after birth.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 May 2013 (estimated)
  2. Study startMay 2013
  3. Primary completionMay 2018
  4. Study completionMay 2018

Why it stopped: New data in public domain suggested continuing study not ethical

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
15 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01864421
Sponsor's protocol ID
13023
Other IDs
13/EM/0129
Acronym
DoppCord
Status last verified
Feb 2016
First submitted
21 May 2013
Last updated
17 May 2018
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

An observational study of Deferred Umbilical Cord Clamping, run by University of Nottingham at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 17 May 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: New data in public domain suggested continuing study not ethical). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Quantification of blood flow in the umbilical cord or skin (time frame: For Doppler the umbilical cord will be scanned until it is clamped (up to 3 minutes). Blood flow to the skin will be measured for up to 20 minutes as long as this is not interfering with normal clinical care.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 May 2018; AzTrials last refreshed its copy on 3 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in